nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimetindene—Olopatadine—S100B—Alzheimer's disease	0.0548	0.167	CrCbGaD
Dimetindene—Dimetacrine—ACHE—Alzheimer's disease	0.0317	0.0966	CrCbGaD
Dimetindene—Amitriptyline—NTRK2—Alzheimer's disease	0.0196	0.0596	CrCbGaD
Dimetindene—Clomipramine—HTR6—Alzheimer's disease	0.013	0.0396	CrCbGaD
Dimetindene—Chlorprothixene—HTR6—Alzheimer's disease	0.013	0.0395	CrCbGaD
Dimetindene—Promethazine—CALM1—Alzheimer's disease	0.0128	0.0389	CrCbGaD
Dimetindene—Nortriptyline—HTR6—Alzheimer's disease	0.0127	0.0387	CrCbGaD
Dimetindene—Doxepin—HTR6—Alzheimer's disease	0.0114	0.0348	CrCbGaD
Dimetindene—Imipramine—HTR6—Alzheimer's disease	0.00889	0.0271	CrCbGaD
Dimetindene—Amitriptyline—HTR6—Alzheimer's disease	0.00883	0.0269	CrCbGaD
Dimetindene—Mepyramine—CYP2D6—Alzheimer's disease	0.00867	0.0264	CrCbGaD
Dimetindene—Tripelennamine—CYP2D6—Alzheimer's disease	0.00803	0.0244	CrCbGaD
Dimetindene—Cyclobenzaprine—HTR2A—Alzheimer's disease	0.00729	0.0222	CrCbGaD
Dimetindene—Cyclobenzaprine—CYP2D6—Alzheimer's disease	0.00667	0.0203	CrCbGaD
Dimetindene—Chlorphenamine—SLC6A4—Alzheimer's disease	0.00664	0.0202	CrCbGaD
Dimetindene—Carbinoxamine—CYP2D6—Alzheimer's disease	0.00549	0.0167	CrCbGaD
Dimetindene—Nortriptyline—PTGS1—Alzheimer's disease	0.00503	0.0153	CrCbGaD
Dimetindene—Clomipramine—SLC6A4—Alzheimer's disease	0.00498	0.0152	CrCbGaD
Dimetindene—Nortriptyline—SLC6A4—Alzheimer's disease	0.00487	0.0148	CrCbGaD
Dimetindene—Brompheniramine—CYP2D6—Alzheimer's disease	0.00475	0.0145	CrCbGaD
Dimetindene—Chlorphenamine—CYP2D6—Alzheimer's disease	0.00466	0.0142	CrCbGaD
Dimetindene—Diphenhydramine—PTGS1—Alzheimer's disease	0.00465	0.0142	CrCbGaD
Dimetindene—Trimipramine—SLC6A4—Alzheimer's disease	0.00459	0.014	CrCbGaD
Dimetindene—Doxepin—SLC6A4—Alzheimer's disease	0.00437	0.0133	CrCbGaD
Dimetindene—Clomipramine—HTR2A—Alzheimer's disease	0.00383	0.0117	CrCbGaD
Dimetindene—Chlorprothixene—HTR2A—Alzheimer's disease	0.00381	0.0116	CrCbGaD
Dimetindene—Nortriptyline—HTR2A—Alzheimer's disease	0.00374	0.0114	CrCbGaD
Dimetindene—Trimipramine—HTR2A—Alzheimer's disease	0.00352	0.0107	CrCbGaD
Dimetindene—Clomipramine—CYP2D6—Alzheimer's disease	0.0035	0.0107	CrCbGaD
Dimetindene—Nortriptyline—CYP2D6—Alzheimer's disease	0.00342	0.0104	CrCbGaD
Dimetindene—Imipramine—SLC6A4—Alzheimer's disease	0.0034	0.0104	CrCbGaD
Dimetindene—Promethazine—HTR2A—Alzheimer's disease	0.00339	0.0103	CrCbGaD
Dimetindene—Amitriptyline—SLC6A4—Alzheimer's disease	0.00338	0.0103	CrCbGaD
Dimetindene—Doxepin—HTR2A—Alzheimer's disease	0.00336	0.0102	CrCbGaD
Dimetindene—Trimipramine—CYP2D6—Alzheimer's disease	0.00322	0.00981	CrCbGaD
Dimetindene—Diphenhydramine—CYP2D6—Alzheimer's disease	0.00317	0.00964	CrCbGaD
Dimetindene—Promethazine—CYP2D6—Alzheimer's disease	0.0031	0.00945	CrCbGaD
Dimetindene—Doxepin—CYP2D6—Alzheimer's disease	0.00307	0.00935	CrCbGaD
Dimetindene—Promazine—HTR2A—Alzheimer's disease	0.00299	0.00909	CrCbGaD
Dimetindene—Imipramine—HTR2A—Alzheimer's disease	0.00261	0.00796	CrCbGaD
Dimetindene—Amitriptyline—HTR2A—Alzheimer's disease	0.0026	0.00791	CrCbGaD
Dimetindene—Imipramine—CYP2D6—Alzheimer's disease	0.00239	0.00728	CrCbGaD
Dimetindene—Amitriptyline—CYP2D6—Alzheimer's disease	0.00238	0.00723	CrCbGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.00207	0.00308	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00205	0.00306	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.00203	0.00303	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—GAL—Alzheimer's disease	0.002	0.00299	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—GAL—Alzheimer's disease	0.00197	0.00294	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.00195	0.00291	CbGpPWpGaD
Dimetindene—CHRM2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.00189	0.00282	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00189	0.00282	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00186	0.00277	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.00184	0.00274	CbGpPWpGaD
Dimetindene—KCNH2—Neuronal System—CREB1—Alzheimer's disease	0.00184	0.00274	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.0018	0.00269	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—F2—Alzheimer's disease	0.00178	0.00265	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00178	0.00264	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.00176	0.00262	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.00173	0.00258	CbGpPWpGaD
Dimetindene—HRH1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.00172	0.00256	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PYY—Alzheimer's disease	0.00163	0.00243	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PYY—Alzheimer's disease	0.00161	0.00239	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.00158	0.00235	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—NPY—Alzheimer's disease	0.00157	0.00234	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—IAPP—Alzheimer's disease	0.00156	0.00233	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00156	0.00232	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—NPY—Alzheimer's disease	0.00155	0.00231	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—IAPP—Alzheimer's disease	0.00154	0.00229	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.00154	0.00229	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CRH—Alzheimer's disease	0.00152	0.00226	CbGpPWpGaD
Dimetindene—HRH1—G alpha (q) signalling events—F2—Alzheimer's disease	0.00151	0.00224	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CRH—Alzheimer's disease	0.00149	0.00223	CbGpPWpGaD
Dimetindene—HRH1—IL-4 Signaling Pathway—AKT1—Alzheimer's disease	0.00149	0.00221	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PYY—Alzheimer's disease	0.00148	0.00221	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PYY—Alzheimer's disease	0.00146	0.00217	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—NPS—Alzheimer's disease	0.00144	0.00214	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CCR5—Alzheimer's disease	0.00144	0.00214	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—NPS—Alzheimer's disease	0.00142	0.00211	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—SST—Alzheimer's disease	0.00137	0.00205	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00136	0.00203	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.00136	0.00202	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—SST—Alzheimer's disease	0.00135	0.00201	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.00135	0.00201	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00134	0.002	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—APP—Alzheimer's disease	0.00134	0.00199	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.00134	0.00199	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.00133	0.00198	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—APP—Alzheimer's disease	0.00132	0.00196	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.00131	0.00195	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CDK5—Alzheimer's disease	0.00129	0.00192	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.00127	0.0019	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CDK5—Alzheimer's disease	0.00127	0.00189	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—HTR6—Alzheimer's disease	0.00124	0.00184	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.00123	0.00183	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—HTR6—Alzheimer's disease	0.00122	0.00182	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.00116	0.00173	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.00116	0.00172	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.00116	0.00172	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.00114	0.0017	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00114	0.00169	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—GAL—Alzheimer's disease	0.00113	0.00169	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00112	0.00167	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—GAL—Alzheimer's disease	0.00111	0.00166	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—GAL—Alzheimer's disease	0.00103	0.00153	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—GAL—Alzheimer's disease	0.00101	0.00151	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TTR—Alzheimer's disease	0.001	0.00149	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000997	0.00149	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TTR—Alzheimer's disease	0.000987	0.00147	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000981	0.00146	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000981	0.00146	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—NPY—Alzheimer's disease	0.00089	0.00133	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000889	0.00132	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000885	0.00132	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000884	0.00132	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PYY—Alzheimer's disease	0.000877	0.00131	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—NPY—Alzheimer's disease	0.000876	0.0013	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000875	0.0013	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	0.000871	0.0013	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	0.00087	0.0013	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000866	0.00129	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	0.000863	0.00128	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CRH—Alzheimer's disease	0.000859	0.00128	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000852	0.00127	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	0.000845	0.00126	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.00084	0.00125	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000814	0.00121	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—NPY—Alzheimer's disease	0.000808	0.0012	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000803	0.0012	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	0.000801	0.00119	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	0.000795	0.00118	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	0.00079	0.00118	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CRH—Alzheimer's disease	0.00078	0.00116	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000776	0.00116	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—SST—Alzheimer's disease	0.000776	0.00116	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	0.000767	0.00114	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000764	0.00114	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	0.000764	0.00114	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CDK5—Alzheimer's disease	0.00076	0.00113	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—F2—Alzheimer's disease	0.00076	0.00113	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—APP—Alzheimer's disease	0.000757	0.00113	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	0.000748	0.00111	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	0.000747	0.00111	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	0.000744	0.00111	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—NPS—Alzheimer's disease	0.000739	0.0011	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000735	0.0011	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HTR6—Alzheimer's disease	0.000732	0.00109	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	0.000727	0.00108	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000724	0.00108	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	0.00072	0.00107	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000714	0.00106	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000705	0.00105	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—SST—Alzheimer's disease	0.000705	0.00105	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000702	0.00105	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	0.000694	0.00103	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	0.000694	0.00103	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—APP—Alzheimer's disease	0.000687	0.00102	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000678	0.00101	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000677	0.00101	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	0.000676	0.00101	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	0.000666	0.000992	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000664	0.000989	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—APH1A—Alzheimer's disease	0.000655	0.000976	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	0.000654	0.000974	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000648	0.000965	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	0.000645	0.00096	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000638	0.00095	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000638	0.00095	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	0.000628	0.000935	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LRP1—Alzheimer's disease	0.000622	0.000927	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	0.000612	0.000912	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GFAP—Alzheimer's disease	0.000608	0.000905	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GAL—Alzheimer's disease	0.000608	0.000905	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	0.000598	0.00089	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	0.000598	0.00089	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—A2M—Alzheimer's disease	0.000536	0.000798	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000533	0.000794	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000528	0.000786	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	0.000527	0.000785	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.00052	0.000774	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000519	0.000772	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	0.00051	0.00076	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.0005	0.000745	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000492	0.000733	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.00049	0.000729	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000482	0.000717	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000479	0.000714	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NPY—Alzheimer's disease	0.000477	0.000711	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IAPP—Alzheimer's disease	0.000474	0.000706	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000472	0.000703	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	0.00047	0.000699	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	0.000467	0.000695	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CRH—Alzheimer's disease	0.000461	0.000686	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000454	0.000677	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	0.000453	0.000675	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	0.000447	0.000666	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000445	0.000662	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000437	0.000651	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NPS—Alzheimer's disease	0.000437	0.00065	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000434	0.000647	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	0.00043	0.00064	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—F2—Alzheimer's disease	0.000429	0.000639	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000428	0.000638	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000427	0.000637	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	0.000422	0.000629	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	0.000421	0.000627	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GAB2—Alzheimer's disease	0.000416	0.00062	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SST—Alzheimer's disease	0.000416	0.00062	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000416	0.00062	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000415	0.000618	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000413	0.000615	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	0.00041	0.00061	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	0.00041	0.00061	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SST—Alzheimer's disease	0.00041	0.00061	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	0.000408	0.000608	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	0.000406	0.000605	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—APP—Alzheimer's disease	0.000406	0.000604	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—APP—Alzheimer's disease	0.000399	0.000595	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—F2—Alzheimer's disease	0.00039	0.00058	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	0.000384	0.000571	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000383	0.00057	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	0.000377	0.000561	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NGFR—Alzheimer's disease	0.000357	0.000532	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CREB1—Alzheimer's disease	0.000355	0.000529	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	0.000352	0.000524	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	0.000349	0.00052	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ADAM10—Alzheimer's disease	0.000349	0.00052	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCL2—Alzheimer's disease	0.000347	0.000517	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	0.000343	0.000511	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	0.000342	0.000509	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—S100B—Alzheimer's disease	0.00033	0.000492	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	0.000325	0.000484	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	0.000314	0.000468	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	0.000309	0.00046	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	0.000304	0.000452	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	0.000299	0.000445	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LPL—Alzheimer's disease	0.000291	0.000434	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	0.000289	0.00043	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	0.000287	0.000427	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	0.000284	0.000423	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	0.000283	0.000422	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	0.000279	0.000415	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NGF—Alzheimer's disease	0.000276	0.000411	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	0.000271	0.000404	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	0.000268	0.0004	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	0.000264	0.000393	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	0.000263	0.000391	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	0.000258	0.000385	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	0.000245	0.000365	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LEP—Alzheimer's disease	0.000244	0.000364	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—APOE—Alzheimer's disease	0.000244	0.000364	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	0.000242	0.00036	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	0.000241	0.000359	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	0.00024	0.000358	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	0.00024	0.000358	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	0.000238	0.000354	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	0.000233	0.000347	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—F2—Alzheimer's disease	0.00023	0.000343	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	0.000229	0.000342	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—F2—Alzheimer's disease	0.000227	0.000337	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000225	0.000336	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000222	0.00033	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	0.000211	0.000315	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	0.00021	0.000312	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—INS—Alzheimer's disease	0.000209	0.000311	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	0.000208	0.00031	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	0.000206	0.000307	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—INS—Alzheimer's disease	0.000205	0.000306	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	0.000205	0.000306	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	0.000202	0.000301	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	0.000202	0.0003	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	0.000199	0.000296	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	0.000183	0.000272	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	0.00018	0.000268	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000157	0.000233	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	0.000155	0.000231	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	0.000154	0.00023	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000154	0.00023	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	0.000153	0.000228	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	0.000152	0.000226	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	0.000143	0.000213	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	0.000142	0.000212	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	0.00014	0.000209	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	0.00014	0.000209	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	0.000132	0.000196	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	0.00013	0.000193	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	0.000121	0.00018	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	0.000119	0.000177	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TP53—Alzheimer's disease	9.96e-05	0.000148	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	9.8e-05	0.000146	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL6—Alzheimer's disease	9.11e-05	0.000136	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	8.97e-05	0.000134	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	8.41e-05	0.000125	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	8.27e-05	0.000123	CbGpPWpGaD
